{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:58:18Z","timestamp":1790884698683,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,5,20]],"date-time":"2016-05-20T00:00:00Z","timestamp":1463702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1038\/npp.2016.75","type":"journal-article","created":{"date-parts":[[2016,5,21]],"date-time":"2016-05-21T14:41:55Z","timestamp":1463841715000},"page":"2704-2713","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":106,"title":["Human Pharmacology of Mephedrone in Comparison with MDMA"],"prefix":"10.1038","volume":"41","author":[{"given":"Esther","family":"Papaseit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"P\u00e9rez-Ma\u00f1\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli\u00e1n-Andr\u00e9s","family":"Mateus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitona","family":"Pujadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francina","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Torrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eul\u00e0lia","family":"Olesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mag\u00ed","family":"Farr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,20]]},"reference":[{"key":"BFnpp201675_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/jat\/bks085","volume":"37","author":"P Adamowicz","year":"2013","unstructured":"Adamowicz P, Tokarczyk B, Stanaszek R, Slopianka M (2013). Fatal mephedrone intoxication\u2014a case report. J Anal Toxicol 37: 37\u201342.","journal-title":"J Anal Toxicol"},{"key":"BFnpp201675_CR2","unstructured":"Advisory Council on the Misuse of Drugs (2015). ACMD report on definitions for the Psychoactive Substances Bill. Report number 454039. Available at: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/454039\/Definitions_report_final_14_august.pdf (last accessed date 5 January 2016)."},{"key":"BFnpp201675_CR3","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/j.1365-2125.1990.tb05447.x","volume":"30","author":"R Brenneisen","year":"1990","unstructured":"Brenneisen R, Fisch HU, Koelbing U, Geissh\u00fcsler S, Kalix P (1990). Amphetamine-like effects in humans of the khat alkaloid cathinone. Br J Clin Pharmacol 30: 825\u2013828.","journal-title":"Br J Clin Pharmacol"},{"key":"BFnpp201675_CR4","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/npp.2011.304","volume":"37","author":"MH Baumann","year":"2012","unstructured":"Baumann MH, Ayestas MA Jr, Partilla JS, Sink JR, Shulgin AT, Daley PF et al (2012). The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37: 1192\u20131203.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201675_CR5","first-page":"3777","volume":"19","author":"FP Busard\u00f2","year":"2015","unstructured":"Busard\u00f2 FP, Kyriakou C, Napoletano S, Marinelli E, Zaami S (2015). Mephedrone related fatalities: a review. Eur Rev Med Pharmacol Sci 19: 3777\u20133790.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"BFnpp201675_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/00004714-200008000-00010","volume":"20","author":"J Cam\u00ed","year":"2000","unstructured":"Cam\u00ed J, Farr\u00e9 M, Mas M, Roset PN, Poudevida S, Mas A et al (2000). Human pharmacology of 3,4-methylenedioxymethamphetamine (\"ecstasy\"): psychomotor performance and subjective effects. J Clin Psychopharmacol 20: 455\u2013466.","journal-title":"J Clin Psychopharmacol"},{"key":"BFnpp201675_CR7","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMra023160","volume":"349","author":"J Cam\u00ed","year":"2003","unstructured":"Cam\u00ed J, Farr\u00e9 M (2003). Drug addiction. N Engl J Med 349: 975\u2013986.","journal-title":"N Engl J Med"},{"key":"BFnpp201675_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.drugalcdep.2011.02.011","volume":"118","author":"RL Carhart-Harris","year":"2011","unstructured":"Carhart-Harris RL, King LA, Nutt DJ (2011). A web-based survey on mephedrone. Drug Alcohol Depend 118: 19\u201322.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp201675_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/00007691-200404000-00009","volume":"26","author":"R de la Torre","year":"2004","unstructured":"de la Torre R, Farr\u00e9 M, Roset PN, Pizarro N, Abanades S, Segura M et al (2004). Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. Ther Drug Monit 26: 137\u2013144.","journal-title":"Ther Drug Monit"},{"key":"BFnpp201675_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1749-6632.2000.tb05199.x","volume":"914","author":"R de la Torre","year":"2000","unstructured":"de la Torre R, Farr\u00e9 M, Roset PN, Lopez CH, Mas M, Ortu\u00f1o J et al (2000). Pharmacology of MDMA in humans. Ann N Y Acad Sci 914: 225\u2013237.","journal-title":"Ann N Y Acad Sci"},{"key":"BFnpp201675_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.pnpbp.2012.07.011","volume":"39","author":"P Deluca","year":"2012","unstructured":"Deluca P, Davey Z, Corazza O, Di Furia L, Farr\u00e9 M, Flesland LH et al (2012). Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project. Prog Neuropsychopharmacol Biol Psychiatry 39: 221\u2013226.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFnpp201675_CR12","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2014a). European Drug Report 2014: Trends and developments. Catalog Number: TDAT14001ENN. Available at: http:\/\/www.emcdda.europa.eu\/publications\/edr\/trends-developments\/2014 (last accessed date 5 January 2016)."},{"key":"BFnpp201675_CR13","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2014b). Perspective on drugs. Injection of synthetic cathinones. Catalog Number: 228233_EN_POD2014. Available at: http:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_228233_EN_POD2014_Injection%20of%20synthetic%20cathinones.pdf . (last accessed date 5 January 2016)."},{"key":"BFnpp201675_CR14","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.euroneuro.2015.05.007","volume":"25","author":"M Farr\u00e9","year":"2015","unstructured":"Farr\u00e9 M, Tomillero A, P\u00e9rez-Ma\u00f1\u00e1 C, Yubero S, Papaseit E, Roset PN et al (2015). Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 4\u2009h apart. Eur Neuropsychopharmacol 25: 1637\u20131649.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFnpp201675_CR15","unstructured":"Farr\u00e9 M, Papaseit E, P\u00e9rez-Ma\u00f1\u00e1 C, Yubero-Lahoz S, Pujadas M, Fonseca F et al (2014). Pharmacokinetics and pharmacodynamics of mephedrone in humans. Res Adv Psychiatry (Suppl1): 19."},{"key":"BFnpp201675_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.forsciint.2014.04.038","volume":"243","author":"E Gerace","year":"2014","unstructured":"Gerace E, Petrarulo M, Bison F, Salomone A, Vincenti M (2014). Toxicological findings in a fatal multidrug intoxication involving mephedrone. Forensic Sci Int 243: 68\u201373.","journal-title":"Forensic Sci Int"},{"key":"BFnpp201675_CR17","first-page":"643878","volume":"201","author":"D Gonz\u00e1lez","year":"2015","unstructured":"Gonz\u00e1lez D, Torrens M, Farr\u00e9 M (2015). Acute effects of the novel psychoactive drug 2C-B on emotions. Biomed Res Int 201: 643878.","journal-title":"Biomed Res Int"},{"key":"BFnpp201675_CR18","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/hup.2323","volume":"28","author":"D Gonz\u00e1lez","year":"2013","unstructured":"Gonz\u00e1lez D, Ventura M, Caudevilla F, Torrens M, Farr\u00e9 M (2013). Consumption of new psychoactive substances in a Spanish sample of research chemical users. Hum Psychopharmacol 28: 332\u2013340.","journal-title":"Hum Psychopharmacol"},{"key":"BFnpp201675_CR19","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1111\/bph.12628","volume":"171","author":"AR Green","year":"2014","unstructured":"Green AR, King MV, Shortall SE, Fone KC (2014). The preclinical pharmacology of mephedrone; not just MDMA by another name. Br J Pharmacol 171: 2251\u20132268.","journal-title":"Br J Pharmacol"},{"key":"BFnpp201675_CR20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00213-012-2761-6","volume":"224","author":"CM Hysek","year":"2012","unstructured":"Hysek CM, Liechti ME (2012). Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex. Psychopharmacology (Berl) 224: 363\u2013376.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201675_CR21","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1111\/j.1476-5381.2011.01499.x","volume":"164","author":"J Kehr","year":"2011","unstructured":"Kehr J, Ichinose F, Yoshitake S, Goiny M, Sievertsson T, Nyberg F et al (2011). Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats. Br J Pharmacol 164: 1949\u20131958.","journal-title":"Br J Pharmacol"},{"key":"BFnpp201675_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jpba.2012.08.015","volume":"72","author":"OI Khreit","year":"2013","unstructured":"Khreit OI, Grant MH, Zhang T, Henderson C, Watson DG, Sutcliffe OB (2013). Elucidation of the Phase I and Phase II metabolic pathways of (\u00b1)-4'-methylmethcathinone (4-MMC) and (\u00b1)-4'-(trifluoromethyl)methcathinone (4-TFMMC) in rat liver hepatocytes using LC-MS and LC-MS. J Pharm Biomed Anal 72: 177\u2013185.","journal-title":"J Pharm Biomed Anal"},{"key":"BFnpp201675_CR23","first-page":"w14043","volume":"145","author":"M Liechti","year":"2015","unstructured":"Liechti M (2015). Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling. Swiss Med Wkly 145: w14043.","journal-title":"Swiss Med Wkly"},{"key":"BFnpp201675_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1476-5381.2012.01998.x","volume":"167","author":"R L\u00f3pez-Arnau","year":"2012","unstructured":"L\u00f3pez-Arnau R, Mart\u00ednez-Clemente J, Pubill D, Escubedo E, Camarasa J (2012). Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone. Br J Pharmacol 167: 407\u2013420.","journal-title":"Br J Pharmacol"},{"key":"BFnpp201675_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00213-013-3108-7","volume":"229","author":"J Mart\u00ednez-Clemente","year":"2013","unstructured":"Mart\u00ednez-Clemente J, L\u00f3pez-Arnau R, Carb\u00f3 M, Pubill D, Camarasa J, Escubedo E (2013). Mephedrone pharmacokinetics after intravenous and oral administration in rats: relation to pharmacodynamics. Psychopharmacology (Berl) 229: 295\u2013306.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201675_CR26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-3565(24)34877-3","volume":"290","author":"M Mas","year":"1999","unstructured":"Mas M, Farr\u00e9 M, de la Torre R, Roset PN, Ortu\u00f1o J, Segura J et al (1999). Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther 290: 136\u2013145.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp201675_CR27","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/anatox\/35.3.188","volume":"35","author":"PD Maskell","year":"2011","unstructured":"Maskell PD, De Paoli G, Seneviratne C, Pounder DJ (2011). Mephedrone (4-methylmethcathinone)-related deaths. J Anal Toxicol 35: 188\u2013191.","journal-title":"J Anal Toxicol"},{"key":"BFnpp201675_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.toxlet.2011.10.010","volume":"208","author":"H Meng","year":"2012","unstructured":"Meng H, Cao J, Kang J, Ying X, Ji J, Reynolds W et al (2012). Mephedrone, a new designer drug of abuse, produces acute hemodynamic effects in the rat. Toxicol Lett 208: 62\u201368.","journal-title":"Toxicol Lett"},{"key":"BFnpp201675_CR29","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s00216-010-3636-5","volume":"397","author":"MR Meyer","year":"2010","unstructured":"Meyer MR, Wilhelm J, Peters FT, Maurer HH (2010). Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry. Anal Bioanal Chem 397: 1225\u20131233.","journal-title":"Anal Bioanal Chem"},{"key":"BFnpp201675_CR30","unstructured":"Mixmag\u2019s Global Drug Survey: The results (2014). Available at: http:\/\/www.globaldrugsurvey.com\/the-global-drug-survey-2014-findings\/ . (last accessed date 4 January 2016)."},{"key":"BFnpp201675_CR31","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1136\/hrt.2010.209338","volume":"96","author":"PJ Nicholson","year":"2010","unstructured":"Nicholson PJ, Quinn MJ, Dodd JD (2010). Headshop heartache: acute mephedrone 'meow' myocarditis. Heart 96: 2051\u20132052.","journal-title":"Heart"},{"key":"BFnpp201675_CR32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/YCO.0000000000000071","volume":"27","author":"E Papaseit","year":"2014","unstructured":"Papaseit E, Farr\u00e9 M, Schifano F, Torrens M (2014). Emerging drugs in Europe. Curr Opin Psychiatry 27: 243\u2013250.","journal-title":"Curr Opin Psychiatry"},{"key":"BFnpp201675_CR33","doi-asserted-by":"publisher","first-page":"e47599","DOI":"10.1371\/journal.pone.0047599","volume":"7","author":"R Pardo-Lozano","year":"2012","unstructured":"Pardo-Lozano R, Farr\u00e9 M, Yubero-Lahoz S, O'Math\u00fana B, Torrens M, Mustata C et al (2012). Clinical pharmacology of 3,4- methylenedioxymethamphetamine (MDMA, \"ecstasy\"): the influence of gender and genetics (CYP2D6, COMT, 5-HTT). PLoS One 7: e47599.","journal-title":"PLoS One"},{"key":"BFnpp201675_CR34","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/dta.1369","volume":"5","author":"AJ Pedersen","year":"2013","unstructured":"Pedersen AJ, Reitzel LA, Johansen SS, Linnet K (2013). In vitro metabolism studies on mephedrone and analysis of forensic cases. Drug Test Anal 5: 430\u2013438.","journal-title":"Drug Test Anal"},{"key":"BFnpp201675_CR35","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00213-012-2894-7","volume":"225","author":"AM Peir\u00f3","year":"2013","unstructured":"Peir\u00f3 AM, Farr\u00e9 M, Roset PN, Carb\u00f3 M, Pujadas M, Torrens M et al (2013). Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2\u2009h apart. Psychopharmacology (Berl) 225: 883\u2013893.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201675_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/jat\/26.3.157","volume":"26","author":"N Pizarro","year":"2002","unstructured":"Pizarro N, Ortu\u00f1o J, Farr\u00e9 M, Hernandez-Lopez C, Pujadas M, Llebaria A et al (2002). Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis. J Anal Toxicol 26: 157\u2013165.","journal-title":"J Anal Toxicol"},{"key":"BFnpp201675_CR37","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1124\/dmd.114.061416","volume":"43","author":"\u00d3J Pozo","year":"2015","unstructured":"Pozo \u00d3J, Ib\u00e1\u00f1ez M, Sancho JV, Lahoz-Beneytez J, Farr\u00e9 M, Papaseit E et al (2015). Mass spectrometric evaluation of mephedrone in vivo human metabolism: identification of phase I and phase II metabolites, including a novel succinyl conjugate. Drug Metab Dispos 43: 248\u2013257.","journal-title":"Drug Metab Dispos"},{"key":"BFnpp201675_CR38","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1136\/emj.2010.103093","volume":"28","author":"L Regan","year":"2011","unstructured":"Regan L, Mitchelson M, Macdonald C (2011). Mephedrone toxicity in a Scottish emergency department. Emerg Med J 28: 1055\u20131058.","journal-title":"Emerg Med J"},{"key":"BFnpp201675_CR39","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0022-3565(25)09566-7","volume":"273","author":"CR Rush","year":"1995","unstructured":"Rush CR, Sullivan JT, Griffiths RR (1995). Intravenous caffeine in stimulant drug abusers: subjective reports and physiological effects. J Pharmacol Exp Ther 273: 351\u2013358.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp201675_CR40","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00213-010-2070-x","volume":"214","author":"F Schifano","year":"2011","unstructured":"Schifano F, Albanese A, Fergus S, Stair JL, Deluca P, Corazza O et al; Psychonaut Web Mapping; ReDNet Research Groups (2011). Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues. Psychopharmacology (Berl) 214: 593\u2013602.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201675_CR41","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1097\/JCP.0b013e318266c70c","volume":"32","author":"F Schifano","year":"2012","unstructured":"Schifano F, Corkery J, Ghodse AH (2012). Suspected and confirmed fatalities associated with mephedrone (4-methylmethcathinone, \"meow meow\") in the United Kingdom. J Clin Psychopharmacol 32: 710\u2013714.","journal-title":"J Clin Psychopharmacol"},{"key":"BFnpp201675_CR42","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","volume":"168","author":"LD Simmler","year":"2013","unstructured":"Simmler LD, Buser TA, Donzelli M, Schramm Y, Dieu LH, Huwyler J et al (2013). Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 168: 458\u2013470.","journal-title":"Br J Pharmacol"},{"key":"BFnpp201675_CR43","doi-asserted-by":"publisher","first-page":"288","DOI":"10.12659\/AJCR.889381","volume":"14","author":"K Sivagnanam","year":"2013","unstructured":"Sivagnanam K, Chaudari D, Lopez P, Sutherland ME, Ramu VK (2013). \"Bath salts\" induced severe reversible cardiomyopathy. Am J Case Rep 14: 288\u2013291.","journal-title":"Am J Case Rep"},{"key":"BFnpp201675_CR44","unstructured":"The vaults of Erowid (2015). 4-methylmethcathinone\/mephedrone. Available at: http:\/\/www.erowid.org\/chemicals\/4_methylmethcathinone\/4_methylmethcathinone.shtml . (last accessed date 4 January 2016)."},{"key":"BFnpp201675_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00204-013-1163-9","volume":"88","author":"MJ Valente","year":"2014","unstructured":"Valente MJ, Guedes de Pinho P, de Lourdes Bastos M, Carvalho F, Carvalho M (2014). Khat and synthetic cathinones: a review. Arch Toxicol 88: 15\u201345.","journal-title":"Arch Toxicol"},{"key":"BFnpp201675_CR46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.toxlet.2010.12.014","volume":"201","author":"I Vardakou","year":"2011","unstructured":"Vardakou I, Pistos C, Spiliopoulou Ch (2011). Drugs for youth via Internet and the example of mephedrone. Toxicol Lett 201: 191\u2013195.","journal-title":"Toxicol Lett"},{"key":"BFnpp201675_CR47","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1111\/j.1360-0443.2011.03502.x","volume":"106","author":"A Winstock","year":"2011","unstructured":"Winstock A, Mitcheson L, Ramsey J, Davies S, Puchnarewicz M, Marsden J (2011). Mephedrone: use, subjective effects and health risks. Addiction 106: 1991\u20131996.","journal-title":"Addiction"},{"key":"BFnpp201675_CR48","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s13181-010-0018-5","volume":"6","author":"DM Wood","year":"2010","unstructured":"Wood DM, Davies S, Puchnarewicz M, Button J, Archer R, Ovaska H et al (2010). Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J Med Toxicol 6: 327\u2013330.","journal-title":"J Med Toxicol"},{"key":"BFnpp201675_CR49","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/emj.2010.092288","volume":"28","author":"DM Wood","year":"2011","unstructured":"Wood DM, Greene SL, Dargan PI (2011). Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone. Emerg Med J 28: 280\u2013282.","journal-title":"Emerg Med J"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp201675.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201675","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201675.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:47:22Z","timestamp":1748972842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp201675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,20]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["BFnpp201675"],"URL":"https:\/\/doi.org\/10.1038\/npp.2016.75","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,20]]},"assertion":[{"value":"7 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}